Cadaver

OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)

Retrieved on: 
Thursday, April 4, 2024
ICSS, Patient, Orthopediatrics, Hospital, Rib, Cadaver, Surgeon, CME, Scoliosis, Adolescent idiopathic scoliosis, Elective surgery, Nursing

WARSAW, Ind., April 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 8th Annual International Children’s Spine Symposium (ICSS), which will take place April 5th and 6th in Denver, Colorado.

Key Points: 
  • WARSAW, Ind., April 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 8th Annual International Children’s Spine Symposium (ICSS), which will take place April 5th and 6th in Denver, Colorado.
  • The meeting, put on by the Armstrong Children’s Orthopedic Alliance, offers a comprehensive program of lectures given by an outstanding, international faculty and cadaver labs centered on the cervical spine, lumbo-sacral junction, neuromonitoring, and various aspects of scoliosis.
  • We consider ICSS to be an interactive forum that allows us to engage with pediatric orthopedic fellows and attending surgeons and train on the latest technologies and surgical techniques.
  • The symposium is always well attended and receives great feedback from attendees, so I am looking forward to this being another productive event.”

One-on-One, Surgeon-to-Surgeon Bunionplasty® Procedure Training Program Sets New Industry Standard for Minimally Invasive Bunion Surgery Adoption

Retrieved on: 
Wednesday, March 27, 2024
Biotechnology, Health, Surgery, Medical Devices, Failure, Medical device, MIS, Voom HD Networks, Surgeon, Learning, Education, Patient, Foot, Interview, Cadaver, DPM, Multimedia, Teaching

Voom™ Medical Devices, Inc. ("Voom"), a revolutionary medical device company transforming the landscape of minimally invasive bunion surgery (MIBS) education, is thrilled to announce the official launch of its new one-on-one surgeon training program for the Bunionplasty® 360 Bunion Repair™ procedure.

Key Points: 
  • Voom™ Medical Devices, Inc. ("Voom"), a revolutionary medical device company transforming the landscape of minimally invasive bunion surgery (MIBS) education, is thrilled to announce the official launch of its new one-on-one surgeon training program for the Bunionplasty® 360 Bunion Repair™ procedure.
  • View the full release here: https://www.businesswire.com/news/home/20240327987468/en/
    Voom™ Medical Devices creates new industry standard with new minimally invasive bunion surgery with one-on-one, surgeon-to-surgeon Bunionplasty® procedure training program.
  • (Graphic: Business Wire)
    Voom hand selects surgeons who apply and interview to become minimally invasive Bunionplasty® procedure trained, and provides them with a comprehensive education and training program.
  • “Hands-on, one-on-one, surgeon-to-surgeon training is now the gold standard for developing confidence with MIBS techniques,” says Dr. Eric Baskin, DPM, FACFAS, Voom Director of Surgeon Training.

Steps2Walk Announces the Impact of Q1 Surgical Mission and Orthopedic Training Programs

Retrieved on: 
Thursday, April 4, 2024
Walking, Partnership, Education, Patient, Foot, Child, Cadaver, Telehealth, Surgeon, Deformity, DRS, Nursing

DENVER, April 4, 2024 /PRNewswire-PRWeb/ -- Steps2Walk, a global humanitarian nonprofit organization providing surgical missions and surgeon training in under-served regions around the world, today announced the patient and educational impact of its first round of programs for 2024. In February and March, the organization conducted programs in Sri Lanka, Pakistan, and for the first time, Tanzania, treating 50 patients and providing surgical training and education to 120 local surgeons.

Key Points: 
  • Founded in 2000 by world-renowned orthopedic surgeon Dr. Mark Myerson , the organization addresses the surgical needs of those with severe foot and ankle deformities in regions where there is limited orthopedic care.
  • Each mission is organized in partnership with the Steps2Walk team, their international network of volunteer surgeons and the hosting medical institutions.
  • Steps2Walk has four upcoming programs scheduled for Q2:
    For more information on how to become a volunteer faculty member or trainee participant in one of the Steps2Walk Programs, visit https://steps2walk.org/faculty/ .
  • Steps2Walk also accepts donations , which can give the gift of walking to those most in need and help fund critical training and education for regional orthopedic surgeons.

Deputy Minister of Ukraine, Nataliia Kalmykova, will be speaking at the LA Convention Center this week

Retrieved on: 
Tuesday, March 12, 2024
Karma, SBMT, Brain, Congress, Brain mapping, Neuroscience, Neurology, Multiple sclerosis, Alzheimer's disease, Ophthalmology, Doe, Knowledge, Los Angeles Convention Center, Associate, Journal, Loma Linda University, Disease, Military medicine, World Congress, AI, Cadaver, Neuro-oncology, Society, Michelson Medical Research Foundation, Journal of Alzheimer's Disease, NASA, Neuroelectrics, Regenerative medicine, Therapy, Spine, Multimedia, Springer Nature, B cell, Neurosurgery

Deputy Minister of Ukraine, Nataliia Kalmykova, will be amongst keynotes ; Ukrainian neurosurgeons from the frontline will also be speaking about combat casualty care and participate in the convention in person.

Key Points: 
  • Deputy Minister of Ukraine, Nataliia Kalmykova, will be amongst keynotes ; Ukrainian neurosurgeons from the frontline will also be speaking about combat casualty care and participate in the convention in person.
  • Since the beginning of the war in Ukraine, SBMT has been supporting Ukrainian doctors with training and medical equipment.
  • The SBMT World Congress is renowned for its comprehensive program, offering a diverse range of presentations, hands-on workshops, Bioskills cadaver labs, and an expansive exhibition hall.
  • Attendees can expect to engage with cutting-edge research, innovative technologies, and expert insights that are shaping the future of neurosciences and neurotechnology.

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Retrieved on: 
Monday, March 11, 2024
Fast Track, Cohort, Research, Orphan drug, FDA, Cardiovascular disease, Treatment, Clinical trial, Exercise, FTD, ODD, Phenotype, Patient, Public expenditure, Hypertrophy, FXN, Heart, Cadaver, G&A, Development, FA, Pharmaceutical industry

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease, today reported fourth quarter and full year 2023 financial results and provided operational highlights.

Key Points: 
  • Data to date suggest that FA patients may have lower FXN levels in the heart versus peripheral tissues.
  • Across all three cardiac biopsies, we observed an increase in FXN levels as measured by liquid chromatography mass spectrometry relative to pre-treatment baseline levels.
  • Lexeo anticipates the gross proceeds from the private placement to be approximately $95.0 million, before deducting any offering related expenses.
  • G&A expenses were $15.4 million for the year ended December 31, 2023, compared to $12.0 million for the same period in 2022.

ZKR Orthopedics Receives IDE Approval for Clinical Trial

Retrieved on: 
Wednesday, February 14, 2024
SAN, Incidence, Degenerative disease, Stair climbing, Orthopedic surgery, FDA, Obesity, Pain, Mutation, Swelling, Exercise, IDE, Visual analogue scale, Conference, Prevalence, Safety, Elective surgery, Canaccord Genuity, Patient, Knee, Cadaver, Investigational device exemption, AAOS, American Academy, Pharmaceutical industry

SAN FRANCISCO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ZKR Orthopedics, Inc., a clinical stage medical device company, announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for a multicenter prospective clinical trial.

Key Points: 
  • SAN FRANCISCO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ZKR Orthopedics, Inc., a clinical stage medical device company, announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for a multicenter prospective clinical trial.
  • We expect the data collected by this trial will establish a strong foundation of compelling clinical evidence for the LIFT implant approval for clinical use," commented David Cash, CEO of ZKR Orthopedics.
  • The IDE approval announcement was made as part of the ZKR Orthopedics activities at the 2024 American Academy of Orthopedic Surgeons annual meeting in San Francisco.
  • In addition to reporting IDE trial approval, the Company participated in the Canaccord Genuity Musculoskeletal Conference earlier this week.

Hundreds of Physicians Rebuke Duke University for Killing Animals to Train Medical Students

Retrieved on: 
Friday, February 2, 2024
University, Education, Health, Publishing, Pharmaceutical, Communications, Research, Animal Welfare, Public Policy, Government, Science, Clinical Trials, COVID-19, Medical school, Molina Healthcare, Anatomy, Physiology, Dog, Stanford University, Harvard University, Animal, Cadaver, Physician, FACC, UNC, Ethics, Letter, Durham station, Student, Cleveland Clinic, Johns Hopkins, Nursing

In a letter sent today to Duke, 552 physicians are urging the university to halt the controversial practice of using and killing animals to train medical students.

Key Points: 
  • In a letter sent today to Duke, 552 physicians are urging the university to halt the controversial practice of using and killing animals to train medical students.
  • The letter, spearheaded by the national medical ethics group Physicians Committee for Responsible Medicine, points out that no other medical school in the United States or Canada is known to kill animals to train students, and none has done so since 2016.
  • Duke only reinstated the practice, in which invasive surgical procedures are performed on pigs, recently and has separately come under fire by medical training experts.
  • “Duke is better than this,” said John Pippin, MD, FACC, director of academic affairs for the Physicians Committee.

AlensiaXR Series A Funding Round to Evolve Anatomical Instruction Using Holograms

Retrieved on: 
Thursday, February 1, 2024
Health Technology, Start-Up, Technology, University, Finance, Education, Apps, Applications, Professional Services, General Health, Artificial Intelligence, Science, Software, Other Science, Health, Research, CWRU, Growth, Case Western Reserve University, Anatomy, Physiology, Faculty, Dissection, Pathology, Investment, Microsoft HoloLens, Learning, Doctor of Philosophy, Student, Series, Finger Lakes Community College, Cadaver, Management

AlensiaXR, a technology company launched by Case Western Reserve University (CWRU), today announced the completion of its Series A funding round to accelerate development and delivery of its HoloAnatomy® learning platform.

Key Points: 
  • AlensiaXR, a technology company launched by Case Western Reserve University (CWRU), today announced the completion of its Series A funding round to accelerate development and delivery of its HoloAnatomy® learning platform.
  • The software revolutionizes anatomical instruction by leveraging advanced holographic technology, reducing the need for costly, resource-intensive cadaver labs.
  • “This milestone marks a significant step forward in the transformation of medical education,” said AlensiaXR CEO Mark Day, who previously led Microsoft’s global HoloLens business.
  • “HoloAnatomy redefines anatomical instruction,” said Mark Griswold, professor at the CWRU School of Medicine and faculty director at the university’s Interactive Commons, which developed the software.

Merz Aesthetics Presents New Data in the Field of Regenerative Aesthetics at the 2024 IMCAS World Congress

Retrieved on: 
Thursday, February 1, 2024
Surgery, Medical Devices, Biotechnology, Other Health, Health, Cosmetics, Retail, Other Science, Science, Abstract, World Congress, Congress, Cadaver, Patient, Fibroblast, Aesthetics, Treatment, CPM, Medical device

Merz Aesthetics is presenting at the 2024 International Master Course on Aging Science (IMCAS) World Congress a total of 5 abstracts highlighting the field of regenerative aesthetics and how its product portfolio is contributing.

Key Points: 
  • Merz Aesthetics is presenting at the 2024 International Master Course on Aging Science (IMCAS) World Congress a total of 5 abstracts highlighting the field of regenerative aesthetics and how its product portfolio is contributing.
  • This year’s IMCAS is the 25th edition of the largest scientific aesthetics congress worldwide beginning Thursday, February 1st to Saturday, February 3.
  • “Merz Aesthetics is looking forward to sharing these new findings, as they provide strong scientific evidence to support the evolving field of regenerative aesthetics,” said Terri Phillips, M.D., Chief Medical Affairs Officer, Merz Aesthetics.
  • Co-authors: Dr. F. Wegener, Dr. Nils Warfving, Dr. Christian Hartmann, Dr. Dr. Thomas Hengl
    Retrospective case series following patients treated with a combination of CPM-HA and CaHA fillers.

Hydration Reimagined: Corpse Reviver Introduces a Revival Blend That Essentializes Your Daily Well-Being

Retrieved on: 
Tuesday, January 9, 2024
Drink, Electrolyte, Alcoholism, Heart, Cadaver, Corpse reviver, Botany, Alchemy, Reviver, Prickly pear, General partnership

DENVER, Jan. 9, 2024 /PRNewswire/ -- Corpse Reviver, the woman-owned beverage brand, is thrilled to introduce the captivating launch of its Hydration Libation. After starting their sister brand Hooch Booch in 2020, founder Anna Zesbaugh realized there was an opportunity to offer better-for-you beverages in both the alcohol and non-alcoholic space. This brand was inspired by a growing desire in society to step into every day with your best foot forward. This electrolyte beverage has three unique flavors (Botanical, Guava Rose, and Prickly Pear). Get ready to indulge in a revitalizing experience designed for daily use.

Key Points: 
  • Corpse Reviver is thrilled to unveil its "Hydration Libation," a daily revival blend of electrolytes, real ingredients, and essential elements.
  • DENVER, Jan. 9, 2024 /PRNewswire/ -- Corpse Reviver, the woman-owned beverage brand, is thrilled to introduce the captivating launch of its Hydration Libation.
  • This brand was inspired by a growing desire in society to step into every day with your best foot forward.
  • We dove headfirst into crafting our Corpse Reviver, your daily dose of electrolytes packed into a can.